l. Provisions, contingent liabilities and contingent
assets
Provisions

Provisions are recognised when the Company has a
present obligation (legal or constructive) as a result of
a past event, it is probable that an outflow of resources
embodying economic benefits will be required to settle
the obligation and a reliable estimate can be made
of the amount of the obligation. When the Company
expects some or all of a provision to be reimbursed,
the reimbursement is recognised as a separate asset,
but only when the reimbursement is virtually certain.
The expense relating to a provision is presented in
the standalone statement of profit and loss net of any
reimbursement. If the effect of the time value of money
is material, provisions are discounted using a current
pre-tax rate that reflects, when appropriate, the risks
specific to the liability. When discounting is used, the
increase in the provision due to the passage of time is
recognised as a finance cost.

Contingent liabilities

A contingent liability is a possible obligation that arises
from past events whose existence will be confirmed
by the occurrence or non-occurrence of one or more
uncertain future events beyond the control of the
Company or a present obligation that is not recognised
because it is not probable that an outflow of resources
will be required to settle the obligation. A contingent
liability also arises in extremely rare cases where there is
a liability that cannot be recognised because it cannot
be measured reliably. The company does not recognize
a contingent liability but discloses its existence in the
standalone financial statements.

Contingent assets

Contingent assets has to be recognised in the financial
statements in the period in which if it is virtually
certain that an inflow of economic benefits will arise.
Contingent assets are assessed continually, and no such
benefits were found for the current financial year.

m. Retirement and other employee benefits

Retirement benefit in the form of provident fund is
a defined contribution scheme. The Company has
no obligation, other than the contribution payable
to the provident fund. The Company recognises the
contribution payable to the provident fund scheme
as an expense, when an employee renders the related
service. If the contribution payable to the scheme for
service received before the balance sheet date exceeds
the contribution already paid, the deficit payable to the
scheme is recognised as a liability after deducting the
contribution already paid. If the contribution already
paid exceeds the contribution due for services received
before the balance sheet date, then excess is recognised
as an asset.

The Company operates a defined benefit plan for its
employees, viz., gratuity. The costs of providing benefits
under the plan are determined on the basis of actuarial
valuation at each year-end using the projected unit
credit method consistent with the advice of qualified
actuaries.

Remeasurements, comprising of actuarial gains
and losses, the effect of the asset ceiling, excluding
amounts included in net interest on the net defined
benefit liability and the return on plan assets (excluding
amounts included in net interest on the net defined
benefit liability), are recognised immediately in the
balance sheet with a corresponding debit or credit to
retained earnings through OCI in the period in which
they occur. Remeasurements are not reclassified to
the standalone statement of profit and loss in the
subsequent periods.

Past service costs are recognised in profit or loss on the
earlier of:

- The date of the plan amendment or curtailment,
and

- The date that the Company recognises related
restructuring costs

Net interest is calculated by applying the discount
rate to the net defined benefit liability or asset. The

Company recognises the following changes in the
net defined benefit obligation as an expense in the
standalone statement of profit and loss:

- Service costs comprising current service costs, past-
service costs, gains and losses on curtailments and
non-routine settlements.

- Net interest expense or income

Accumulated leave, which is expected to be utilized
within the next 12 months, is treated as short-term
employee benefit. The Company measures the expected
cost of such absences as the additional amount that it
expects to pay as a result of the unused entitlement
that has accumulated at the reporting date.

The Company treats accumulated leave expected to be
carried forward beyond twelve months, as long-term
employee benefit for measurement purposes. Such
long-term compensated absences are provided for
based on the actuarial valuation using the projected
unit credit method at the year-end. Actuarial gains/
losses are immediately taken to the statement of profit
and loss and are not deferred. The company presents
the entire leave as a current liability in the balance
sheet, since it does not have an unconditional right to
defer its settlement for 12 months after the reporting
date.

n. Employee share-based payments

Employees (including senior executives) of the
Company receive remuneration in the form of share
based payment transactions, whereby employees
render services as consideration for equity instruments.

The cost of equity-settled transactions is determined by
the fair value at the date when the grant is made using
an appropriate valuation model.

That cost is recognised, together with a corresponding
increase in share-based payment (SBP) reserves in
equity, over the period in which the performance and/
or service conditions are fulfilled in employee benefits
expense. The cumulative expense recognised for
equity-settled transactions at each reporting date until
the vesting date reflects the extent to which the vesting
period has expired and the Company's best estimate of
the number of equity instruments that will ultimately
vest.

The standalone statement of profit and loss expense
or credit for a period represents the movement in
cumulative expense recognised as at the beginning
and end of that period and is recognised in employee
benefits expense.

The amount of expenses pertaining to options granted
to employees of the Company's subsidiaries are treated
as Deemed Investments in respective subsidiaries to
which employees belong and are recognised at each
reporting period date until the vesting date, with
corresponding impact in Share-based payment reserve.

Service and non-market performance conditions are not
taken into account when determining the grant date
fair value of awards, but the likelihood of the conditions
being met is assessed as part of the Company's best
estimate of the number of equity instruments that will
ultimately vest. Market performance conditions are
reflected within the grant date fair value.

Any other conditions attached to an award, but without
an associated service requirement, are considered to
be non-vesting conditions. Non-vesting conditions are
reflected in the fair value of an award and lead to an
immediate expensing of an award unless there are also
service and/or performance conditions.

No expense is recognised for awards that do not
ultimately vest because non-market performance
and/or service conditions have not been met. Where
awards include a market or non-vesting condition,
the transactions are treated as vested irrespective
of whether the market or non-vesting condition is
satisfied, provided that all other performance and/or
service conditions are satisfied.

When the terms of an equity-settled award are modified,
the minimum expense recognised is the expense had
the terms had not been modified, if the original terms of
the award are met. An additional expense is recognised
for any modification that increases the total fair value
of the share-based payment transaction, or is otherwise
beneficial to the employee as measured at the date
of modification. Where an award is cancelled by the
entity or by the counterparty, any remaining element
of the fair value of the award is expensed immediately
through statement of profit and loss.

The dilutive effect of outstanding options is reflected as
additional share dilution in the computation of diluted
earnings per share, unless its anti-dilutive to Company's
earnings in nature.

Shares allotted to Trust:

The Company has created an Employees benefit
trust (Trust) for implementation of the schemes that
are notified or may be notified from time to time by
the Company under the plan, providing share based
payment to its employees. The company allocated
shares to Trust at the time of formation of trust. The
Company treats trust as its extension and these equity

instruments are recognised at cost and deducted from
equity.

o. Financial Instruments

A financial instrument is any contract that gives rise to
a financial asset of one entity and a financial liability or
equity instrument of another entity.

Financial assets

Initial recognition and measurement

All financial assets are recognised initially at fair value
plus except for trade receivables, less transaction costs
that are attributable to the acquisition of the financial
asset. Purchases or sales of financial assets that require
delivery of assets within a time frame established by
regulation or convention in the market place (regular
way trades) are recognised on the trade date, i.e., the
date that the Company commits to purchase or sell the
asset. However, trade receivables that do not contain
a significant financing component are measured at
transaction price.

Subsequent measurement

For purposes of subsequent measurement, financial
assets are classified in four categories:

i) Debt instruments at amortised cost

ii) Debt instruments at fair value through other
comprehensive income (FVTOCI)

iii) Debt instruments, derivatives and equity
instruments at fair value through profit or loss
(FVTPL)

iv) Equity instruments measured at fair value through
other comprehensive income (FVTOCI)

Debt instruments at amortised cost

A 'debt instrument' is measured at the amortised cost if
both the following conditions are met:

a) The asset is held within a business model whose
objective is to hold assets for collecting contractual
cash flows, and

b) Contractual terms of the asset give rise on specified
dates to cash flows that are solely payments
of principal and interest (SPPI) on the principal
amount outstanding.

After initial measurement, such financial assets are
subsequently measured at amortised cost using the
effective interest rate (EIR) method. Amortised cost
is calculated by taking into account any discount or
premium on acquisition and fees or costs that are an

integral part of the EIR. The EIR amortisation is included
in other income in the statement of profit and loss. The
losses arising from impairment are recognised in the
statement of profit and loss. This category generally
applies to trade and other receivables.

Derecognition

A financial asset (or, where applicable, a part of a
financial asset or part of a group of similar financial
assets) is primarily derecognised (i.e. removed from the
Company's balance sheet) when:

- the rights to receive Cash flows from the asset have
expired, or

- The Company has transferred its rights to receive
cash flows from the asset or has assumed an
obligation to pay the received cash flows in full
without material delay to a third party under a
'pass-through' arrangement; and either (a) the
Company has transferred substantially all the risks
and rewards of the asset, or (b) the Company has
neither transferred nor retained substantially all the
risks and rewards of the asset, but has transferred
control of the asset.

When the Company has transferred its rights to receive
cash flows from an asset or has entered into a pass¬
through arrangement, it valuates if and to what extent it
has retained the risks and rewards of ownership. When
it has neither transferred nor retained substantially all
of the risks and rewards of the asset, nor transferred
control of the asset, the Company continues to recognise
the transferred asset to the extent of the Company's
continuing involvement. In that case, the Company
also recognises an associated liability. The transferred
asset and the associated liability are measured on a
basis that reflects the rights and obligations that the
Company has retained.Continuing involvement that
takes the form of a guarantee over the transferred asset
is measured at the lower of the original carrying amount
of the asset and the maximum amount of consideration
that the Company could be required to repay.

Impairment of financial assets

In accordance with Ind AS 109, the Company applies
expected credit loss (ECL) model for measurement
and recognition of impairment loss on the following
financial assets and credit risk exposure:

a) financial assets that are debt instruments, and
are measured at amortized cost e.g., loans, debt
securities, deposits, trade receivables and bank
balance.

b) Financial assets that are debt instruments and are
measured as at FVTOCI.

The Company recognises loss allowances for expected
credit losses on:

- financial assets measured at amortised cost.

At each reporting date, the Company assesses
whether financial assets carried at amortised cost are
credit-impaired. A financial asset is 'credit-impaired'
when one or more events that have a detrimental
impact on the estimated future cash flows of the
financial asset have occurred.

The Company measures loss allowances at an amount
equal to lifetime expected credit losses. In case of
loss allowance of trade receivables, the Company
follows a simplified approach wherein an amount
equal to lifetime ECL is measured and recognised as
loss allowance. Lifetime expected credit losses are
the expected credit losses that result from all possible
default events over the expected life of a financial
instrument.

12-month expected credit losses are the portion of
expected credit losses that result from default events
that are possible within 12 months after the reporting
date (or a shorter period if the expected life of the
instrument is less than 12 months).

In all cases, the maximum period considered when
estimating expected credit losses is the maximum
contractual period over which the Company is exposed
to credit risk.

When determining whether the credit risk of a financial
asset has increased significantly since initial recognition
and when estimating expected credit losses, the
Company considers reasonable and supportable
information that is relevant and available without
undue cost or effort. This includes both quantitative
and qualitative information and analysis, based on the
Company's historical experience and informed credit
assessment and including forward-looking information.

The Company assumes that the credit risk on a financial
asset has increased significantly if it is more than 180
days past due.

The Company considers a financial asset to be in default
when:

- the debtor is unlikely to pay its credit obligations to
the Group in full, without recourse by the Group to
actions such as realising security (if any is held); or

- the financial asset is more than 365 days past due.

Measurement of expected credit losses:

Expected credit losses are a probability-weighted
estimate of credit losses. Credit losses are measured
as the present value of all cash shortfalls (i.e. the
difference between the cash flows due to the Company
in accordance with the contract and the cash flows that
the Company expects to receive).

Presentation of allowance for expected credit losses in
the balance sheet

Loss allowances for financial assets measured at
amortised cost are deducted from the gross carrying
amount of the as sets.Presentation of allowance for
expected credit losses in the balance sheetThe gross
carrying amount of a financial asset is written off
when the Company has no reasonable expectations of
recovering the financial asset in its entirety or a portion
thereof. A write-off constitutes a derecognition event.

Equity and Compound Financial Instruments

The debt and equity instruments that are issued are
classified as either financial liabilities or as equity in
accordance with the substance of the contractual
arrangement.

Financial liabilities are classified, at initial recognition,
as financial liabilities at fair value through profit or loss,
loans and borrowings, payables, as appropriate.

All financial liabilities are recognised initially at fair value
and, in the case of loans and borrowings and payables,
net of directly attributable transaction costs .

The Company's financial liabilities include trade and
other payables, loans and borrowings including bank
overdrafts, financial guarantee contracts.

Equity:

An equity instrument is any contract that evidences
a residual interest in the assets of an entity after
deducting all of its liabilities. Equity instruments
issued by the company are recognised at the proceeds
received, net of direct issue costs.

A conversion option that will be settled by the exchange
of a fixed amount of cash or another financial asset for a
fixed number of the Company's own equity instruments
is an equity instrument.

Subsequent measurement

The measurement of financial liabilities depends on
their classification, as described below:

Financial liabilities at fair value through profit or
loss

Financial liabilities at fair value through profit or loss
include financial liabilities held for trading and financial
liabilities designated upon initial recognition as at fair
value through profit or loss. Financial liabilities are
classified as held for trading if they are incurred for the
purpose of repurchasing in the near term.

Gains or losses on liabilities held for trading are
recognised in the standalone statement of profit and
loss.

Financial liabilities designated upon initial recognition
at fair value through profit or loss are designated as such
at the initial date of recognition, and only if the criteria
in Ind AS 109 are satisfied. For liabilities designated as
FVTPL, fair value gains/ losses attributable to changes
in own credit risk are recognised in OCI. These gains/
losses are not subsequently transferred to the statement
of profit and loss. However, the Company may transfer
the cumulative gain or loss within equity. All other
changes in fair value of such liability are recognised in
the standalone statement of profit and loss.

Loans and borrowings

After initial recognition, interest-bearing loans and
borrowings are subsequently measured at amortised
cost using the EIR method. Gains and losses are
recognised in the statement of profit and loss when the
liabilities are derecognised as well as through the EIR
amortisation process.

Amortised cost is calculated by taking into account any
discount or premium on acquisition and fees or costs
that are an integral part of the EIR. The EIR amortisation
is included as finance costs in the standalone statement
of profit and loss.

Derecognition

A financial liability is derecognised when the obligation
under the liability is discharged or cancelled or expires.
When an existing financial liability is replaced by another
from the same lender on substantially different terms,
or the terms of an existing liability are substantially
modified, such an exchange or modification is treated
as the derecognition of the original liability and the
recognition of a new liability. The difference in the
respective carrying amounts is recognised in the
standalone statement of profit and loss.

The Company also derecognises a financial liability
when its terms are modified and the cash flows under
the modified terms are substantially different.

Offsetting of financial instruments

Financial assets and financial liabilities are offset and
the net amount is reported in the balance sheet if
there is a currently enforceable legal right to offset
the recognised amounts and there is an intention to
settle on a net basis, to realise the assets and settle the
liabilities simultaneously.

p. Financial Guarantee

In a financial guarantee where the parent company has
provided guarantee to its subsidiaries, Company treats
the fair value of the guarantee as an equity infusion
at the time of initial recognition and subsequently
recognize the Guarantee premium over the period of
guarantee.

q. Cash and cash equivalents

Cash and cash equivalent in the balance sheet comprise
cash at banks and on hand and short-term deposits
with an original maturity of three months or less, which
are subject to an insignificant risk of changes in value.

For the purpose of the standalone statement of cash
flows, cash and cash equivalents consist of cash
and short-term deposits, as defined above, net of
outstanding bank overdrafts as they are considered an
integral part of the Company's cash management.

r. Investment in subsidiaries

Investments in subsidiaries are carried at cost less
accumulated impairment losses, if any. Where an
indication of impairment exists, the carrying amount
of the investment is assessed and written down
immediately to its recoverable amount.

On disposal of investments in subsidiaries, the
difference between net disposal proceeds and the
carrying amounts are recognised in the standalone
statement of profit and loss.

s. Interest income

Interest income from financial instruments measured
either at amortised cost or at fair value through other
comprehensive income is recorded using the effective
interest rate (EIR). EIR is the rate that exactly discounts
the estimated future cash payments or receipts over
the expected life of the financial instrument or a
shorter period, where appropriate, to the gross carrying
amount of the financial asset or to the amortised cost
of a financial liability. When calculating the effective
interest rate, the Company estimates the expected
cash flows by considering all the contractual terms of
the financial instrument (for example, prepayment,
extension, call and similar options) but does not
consider the expected credit losses. Interest income is

included in other income in the standalone statement
of profit and loss.

t. Rental Income

Rental income arising from operating leases on building
is accounted for on a straight-line basis over the lease
terms and is included in revenue in the statement of
profit and loss due to its operating nature.

u. Earnings per equity share

Basic earnings equity per share is calculated by dividing
the net profit or loss attributable to equity holder of
parent company (after deducting preference dividends
and attributable taxes) by the weighted average
number of equity shares outstanding during the period.
Partly paid equity shares are treated as a fraction of
an equity share to the extent that they are entitled to
participate in dividends relative to a fully paid equity
share during the reporting period. Equity shares that
will be issued upon the conversion of a mandatorily
convertible instrument are included in the calculation
of basic earnings per share from the date the contract
is entered into. The weighted average number of equity
shares outstanding during the period is adjusted for
events such as bonus issue, bonus element in a rights
issue, share split, and reverse share split (consolidation
of shares) that have changed the number of equity
shares outstanding, without a corresponding change in
resources.

For the purpose of calculating diluted earnings equity
per share, the net profit or loss for the period attributable

to equity shareholders and the weighted average
number of shares outstanding during the period are
adjusted for the effects of all dilutive potential equity
shares.

v. Cash flow statement

Cash flow statement is prepared in accordance with the
indirect method prescribed in Ind AS 7 'Statement of
Cash Flows.

w. events after Reporting date

Where events occurring after the Balance Sheet date
provide evidence of conditions that existed at the end
of the reporting period, the impact of such events is
adjusted within the standalone financial statements.
Otherwise, events after the Balance Sheet date of
material size or nature are only disclosed.

x. Recent pronouncements

Ministry of Corporate Affairs ("MCA") notifies new
standards or amendments to the existing standards
under Companies (Indian Accounting Standards) Rules
as issued from time to time. During the year ended 31
March 2026, MCA has notified amendment to Ind AS
21 - The Effects of Changes in Foreign Exchange Rates,
Ind AS 1 - Presentation of Financial Statements, Ind
AS 7 - Statement of Cash Flows, Ind AS 107 - Financial
Instruments, Ind AS 12 -Income Taxes, applicable to
the Company w.e.f. April 1, 2025. The Company has
reviewed the amendments and based on its evaluation
has determined that these amendments will not have
any significant impact in its financial statements.

Note : 36,579 equity shares were issued as a result of the exercise of vested options arising from the MedPlus Employee Stock
Options and Shares Plan, 2021 (ESOP 2021) granted to key management personnel (31 March 2025: Nil) (see Note 34 ). Options
were exercised at an average price of C549.03 per share.

(b) Terms and rights attached to equity shares

The Company has a single class of equity shares having par value of C2 per share (March 31,2025: C2 per share). Accordingly,
all equity shares rank equally with regard to dividends and share in the Company's residual assets on winding up. The equity
shareholders are entitled to receive dividend as declared from time to time, subject to preferential right of preference
shareholders to payment of dividend. The voting rights of an equity shareholder on a poll (not on show of hands) are in
proportion to the share of paid-up equity share capital of the Company. Voting rights cannot be exercised in respect of shares
on which any call or other sums presently payable has not been paid. Failure to pay any amount called up on shares may lead
to their forfeiture. On winding up of the Company, the holders of equity shares will be entitled to receive the residual assets of
the Company, remaining after distribution of all preferential amounts, in proportion to the number of equity shares held.

Nature and purpose of reserves

a) Securities premium

Securities premium is used to record the premium on issue of shares. The premium will be utilised in accordance with the
provisions of the Act.

b) Share based payment reserve

The Company has granted equity settled share based payment plans for certain categories of employees of the Company.
(refer note 34).

c) General Reserve

General reserve is used from time to time to transfer profit from reserves, for appropriation purposes.

d) Retained earnings

Retained earnings are profits that the Company has earned till date, less any transfers to general reserve, dividends or other
distributions paid to shareholders.

e) Capital reserve

Capital reserve represents reserve created as part of common control business combination during the financial year FY 2020¬
21.

Note 1: The Company had received a demand notice from the Income tax authorities pertaining to FY 2020¬
21, amounting to C32.37 due to certain disallowances and additions to the total income. The Company
has filed an appeal with the Commissioner of Income Tax (Appeals) challenging the said demand.
Based on the assessment of the notice and the underlying facts by an independent external consultant, the Company is
confident that the matter will be settled in the Company's favour. Consequently, no adjustments have been made to the
standalone financial statements in this regard.

33. Employee benefits

I. Post Employment Benefits

A. Defined benefits plan - Gratuity

Company has a defined benefit plan which provides for gratuity payments for its employees. Under the plan, every employee
who has completed at least five years of service is entitled to gratuity equivalent fifteen days salary last drawn for each
completed year of service in accordance with the Code on Social Security, 2020. The same is payable at the time of separation
from the company. The scheme is partly funded in the form of a qualifying insurance policy managed by Life Insurance
Corporation of India.

The defined benefit plan exposes the company to actuarial risks such as longetivity risk, interest rate risk and market/investment
risk.

Interest Rate risk: The plan exposes the Company to the risk of fall in interest rates. A fall in interest rates will result in an increase
in the ultimate cost of providing the above benefit and will thus result in an increase in the value of the liability.

Investment Risk: The probability or likelihood of occurrence of losses relative to the expected return on any particular
investment.

Liquidity Risk: This is the risk that the Company is not able to meet the short-term gratuity payouts. This may arise due to non¬
availability of enough cash / cash equivalent to meet the liabilities or holding of illiquid assets not being sold in time.

The Company has determined that, in accordance with the terms and conditions of the gratuity plan, and in accordance with
statutory requirements (including minimum funding requirements) of the plan of the relevant jurisdiction, the present value of
refund or reduction in future contributions is not lower than the balance of the total fair value of the plan assets less the total
present value of obligations. As such, no decrease in the defined benefit asset is necessary at March 31,2026 (March 31,2025:

B. Defined Contribution Plan
Provident fund and other funds

The Company makes contributions, determined as a specified percentage of employee salaries, in respect of qualifying
employees towards provident fund and Employee state insurance, which is defined contribution plan. The Company has no
obligations other than to make specified contributions. The contributions are charged to the statement of profit and loss as
they accrue.

The amount recognised as an expense towards contribution to provident fund and employee state insurance for the year
aggregated to C30.19 (March 31,2025: C25.52) (refer note 27).

II. Other benefits - Leave Encashment

The employees of the Company are entitled to leave encashment which are both accumulating and non-accumulating in
nature. The expected cost of accumulating leave encashment is determined by actuarial valuation based on the additional
amount expected to be paid as a result of the unused entitlement that has accumulated at the balance sheet date. Expense on
non-accumulating leaves is recognized in the year in which the absences occur.

The amount recognised as an expense towards leave compensated absences for the year aggregated to C13.72 (March 31,
2025: C6.93).

III. Impact of new Labour Codes

During the year ended March 31, 2026, the Central Government of India notified the Code on Wages, 2019, the Industrial
Relations Code, 2020, the Code on Social Security, 2020, and the Occupational Safety, Health and Working Conditions Code,
2020, collectively referred to as the 'New Labour Codes', effective from November 21, 2025 primarily impacting the wage
definition to be considered for the purpose of defined benefit obligation relating to gratuity and defined benefit contribution
relating to leave encashment.

As a result of this plan amendment, the Company's defined benefit obligation and defined benefit contribution increased by
C1.58 and C0.47 respectively (March 31,2025: Nil). A corresponding past service cost was recognized in the statement of profit
and loss during the current year. The Company continues to monitor the Central / State Rules as notified and clarifications from
the Government on other aspects of the Labour Code and would provide appropriate accounting effect on the basis of such
developments as needed.

34. Employee stock option plan

(i) MedPlus Employees Stock Option and Shares Plan 2009 (ESOP 2009)

(a) The Company instituted MedPlus Employees Stock Option and Shares Plan 2009 (ESOP 2009). The Board of directors
approved the plan on November 16, 2009. The plan is effective from November 1,2009 which provided for issue of 9,673
stock options to eligible employees. The options vest over a period of four years or as approved by remuneration committee
and would be settled by issue of fully paid equity shares.

Pursuant to a resolution passed by the Board of Directors on February 17, 2011, the Company had formed a trust (MedPlus
Employee Benefit Trust) to implement and administer ESOP 2009 and had allotted 9,673 options to the Trust.

The Company has allotted (before giving impact of bonus and split) 4,110 equity options and 5,563 options to the trust
at premium of C11,016 per Option and C5,781 per Option respectively, aggregating total securities premium of C77.44
millions

Amount receivable from the trust for options granted aggregating to C77.54 (Face value - C0.10 and Premium of C77.44)
has been accounted as 'Amount recoverable from Trust in kind' and has been deducted from share capital and securities
premium respectively as these are in the nature of own shares held. The same will be adjusted at the time of exercise of
options by the employees.

During the year March 31,2026 8 (March 31,2025: 138) options were exercised by employees which resulted in

(i) increase in paid up capital by March 31,2026 C0.00 (March 31,2025: C0.00) and

(ii) increase of securities premium by March 31,2026 CNil (March 31,2025: CNil)

Further, recovery of C0.00 (March 31, 2025: C9.92) from ESOP trust was done on account of exercised options during the
year ended March 31,2026"

(ii) MedPlus Employees Stock Option and Shares Plan 2021 (ESOP 2021)

(a) The Company instituted MedPlus Employees Stock Option and Shares Plan 2021 (ESOP 2021). The Board of directors
approved the plan on August 9, 2021. The plan is effective from August 9, 2021 which provided for issue of 1,117,612 stock
options to eligible employees. The options vest over a period of four years from the grant date at 10%, 25%, 25% and 40%
respectively, as a % of options granted. Vesting period may be accelerated on deserving cases, subject to applicable law
and minimum vesting period of at least one year. During the year ended March 31, 2026 the Company has granted Nil
(March 31, 2025: Nil) Options.

35.Leases

The Company recognises right-of-use asset representing its right to use the underlying asset for the lease term at the lease
commencement date. The cost of the right-of-use asset measured at inception shall comprise of the amount of the initial
measurement of the lease liability adjusted for any lease payments made at or before the commencement date less any lease
incentives received, plus any initial direct costs incurred and an estimate of costs to be incurred by the lessee in dismantling
and removing the underlying asset or restoring the underlying asset or site on which it is located. The right-of-use assets
is subsequently measured at cost less any accumulated depreciation, accumulated impairment losses, if any and adjusted
for any remeasurement of the lease liability. The right-of-use assets is depreciated using the straight-line method from the
commencement date over the shorter of lease term or useful life of right-of-use asset.

36. Operating segment

The Company has presented segment information in the consolidated financial statements. Accordingly, in terms of paragraph
3 of Ind AS 108 'Operating Segments', no disclosures related to segment are presented in these standalone financial statements.

37. Capital Commitments
Commitments

As at March 31, 2026 the Company has commitments of C11.97 relating to contracts remaining to be executed on capital
account, net of advance. (March 31,2025: C0.88)

38. Details of dues of micro enterprises and small enterprises as defined under the MSMED Act, 2006

The Ministry of Micro, Small and Medium Enterprises has issued an Office Memorandum dated August 26, 2008 which
recommends that the Micro and Small Enterprises should mention in their correspondence with its customers the Entrepreneurs
Memorandum Number as allocated after filling the Memorandum. Accordingly, the disclosure in respect of the amounts
payable to such enterprises as at March 31,2026 has been made in the standalone financial statements based on information
received and available with the Company. The Company has not received any claim for interest from any supplier under the
said Act.

Note:

1. Outstanding balances for trade receivable, trade payable and other payables are unsecured, interest free and settlement
occurs in cash. The Company has recorded impairment of balances relating to amounts owed by related party, provision
for bad and doubtful debts will be made on an aggregate basis i.e. not specific to party. The assessment is undertaken
each financial year through evaluating the financial position of the related party and the market in which the related party
operates.

2. Managerial remuneration does not include post employment benefit which is determined for Company as whole.

40. Financial instruments Fair Values

Refer note 2.2 (o.) for accounting policy on Financial Instruments.

Set out below, is a comparison by class of the carrying amounts of the Company's financial instruments:

The fair value of trade receivables, cash and cash equivalents, bank balances, other than cash and cash equivalents, loans, other
financial assets, trade payables, lease liabilities and other financial liabilities approximate their carrying amount largely due to
short time nature of these instruments.

Fair value hierarchy

Refer note 2.2d for accounting policy on Fair value.

There are no transfers between levels 1 and 2 during the year ended March 31,2026 and March 31,2025.

41. Financial risk management

The Company has exposure to the following risks arising from financial instruments:

1. Credit risk

2. Liquidity risk"

3. Market risk

Risk management framework:

The Company's Board of Directors has overall responsibility for the establishment and deployment of risk management
framework. The Board of Directors has adopted a Risk Policy, which empowers the management to access and monitoring the
risk management parameters along with action taken and the same is updated to Board of Directors."

The Company's risk management policies are established to identify and analyse the risks being faced by the Company, to set
appropriate risk limits and controls and to monitor risks and adherence to limits. Risk management policies and systems are
reviewed regularly to reflect changes in market conditions and the Company's activities. The Company, through its training
and management standards and procedures, aims to maintain a disciplined and constructive control environment in which all
employees understand their roles and obligations.

The Company's audit committee oversees how management monitors compliance with the Company's risk management
policies and procedures, and reviews the adequacy of the risk management framework in relation to the risk faced by the
Company. The audit committee is assisted in its oversight role by internal audit. Internal audit undertakes both regular and
adhoc reviews of risk management controls and procedures, the result of which are reported to the audit committee.

Market risk

Market risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in
market prices. Such changes in the values of financial instruments may result from changes in the credit, interest rate, liquidity
and other market changes. The Company's Financial instruments are not affected by market risk.

Credit risk

Credit risk is the risk that counterparty will not meet its obligations under a financial instrument or customer contract,
leading to a financial loss. Credit risk encompasses of both, the direct risk of default and the risk of deterioration of
creditworthiness as well as concentration of risks. Credit risk is controlled by analysing credit limits and creditworthiness
of customers on a continuous basis to whom the credit has been granted after obtaining necessary approvals for credit.
Financial instruments that are subject to concentrations of credit risk principally consist of trade receivables, cash and cash
equivalents, bank deposits and other financial assets. None of the financial instruments of the Company result in material
concentration of credit risk, except for trade receivables.

The Company primarily supplies goods to its subsidery companies which are made on credit. It generally operates on Cash and
Carry model in the diagnostic services line, however sale to certain institutional customers are made on credit. Credit terms
are generally 30 to 60 days. The customer credit risk is managed by the Company's established policy, procedures and control
relating to customer credit risk management. Credit quality of a customer is assessed based on the individual credit limits as
defined in accordance with this assessment and outstanding customer receivables are regularly monitored. The Company'
receivables turnover is quick and historically, there was no significant defaults on account of those customer in the past. Ind AS
requires an entity to recognise in profit or loss, the amount of expected credit losses (or reversal) that is required to adjust the
loss allowance at the reporting date to the amount that is required to be recognised in accordance with Ind AS 109.

The Company assesses financial position at each reporting date whether a financial asset or a group of financial assets is
impaired. Expected credit losses are measured at an amount equal to the 12 month expected credit losses or at an amount equal
to the life time expected credit losses if the credit risk on the financial asset has increased significantly since initial recognition.
The Company has used a practical expedient by computing the expected credit loss allowance for trade receivables based on
a provision matrix. The provision matrix takes into account historical credit loss experience and adjusted for forward-looking
information. Since 99.89% of the trade receivables are from related parties, no credit risk is observed.

Exposure to credit risk:

The carrying amount of financial assets represents the maximum credit exposure. The maximum exposure to credit risk was
C1326.06, C1216.29 as of March 31,2026 and March 31,2025 respectively, being the total of the carrying amount of balances
with trade receivables that includes receivable from subsidiaries amounting to C1,324.59 where no risk is associated.

Cash and cash equivalents and other bank balances

The cash and cash equivalents and other bank balances are held with banks. Credit risk on cash and cash equivalents and
deposits with banks and financial institutions are generally low as the said deposits have been made with the banks and
financial institutions who have been assigned high credit rating by international and domestic credit rating agencies.

Loans

The Company has advanced interest bearing long-term loan to its subsidiary Kalyani Meditimes Private Limited. An amount of
impairment allowance of C17.82 (31 March 2025: C17.82) has been recognized.

Security deposits and other financial assets

Security deposits are primarily given for acquiring right to the leased asset. Recoverability of these deposits is probable and the
Management considers them to be low credit risk. An amount of impairment allowance of C11.67 (31 March 2025: C11.67) has
been recognized.

Liquidity risk

Liquidity risk refers to the risk that the Company cannot meet its financial obligations. The objective of liquidity risk management
is to maintain sufficient liquidity and ensure that funds are available for use as per requirements. The Company manages
liquidity risk by maintaining adequate reserves, banking facilities and reserve borrowing facilities, by continuously monitoring
forecast and actual cash flows, and by matching the maturity profiles of financial assets and liabilities.

The Company has deployed its surplus funds into various financial instruments including liquid and overnight Mutual funds.
The Company is exposed to price risk on such investments, which arises on account of movement in interest rates, liquidity and
credit quality of underlying securities.

Excessive risk concentration

Concentrations arise when a number of counterparties are engaged in similar business activities, or activities in the same
geographical region, or have economic features that would cause their ability to meet contractual obligations to be similarly
affected by changes in economic, political or other conditions. Concentrations indicate the relative sensitivity of the Company's
performance to developments affecting a particular industry.

In order to avoid excessive concentrations of risk, the Company's policies and procedures include specific guidelines to focus
on the maintenance of a diversified portfolio. Identified concentrations of credit risks are controlled and managed accordingly.

42. Capital Management

For the purpose of the Company's capital management, capital includes issued equity capital and all other equity reserves
attributable to the equity holders. The primary objective of the Company's capital management is to maximise the shareholder
value.

The Company manages its capital structure in consideration to the changes in economic conditions. The Company monitors
capital using a gearing ratio, which is net debt divided by total capital plus net debt. The Company includes within net debt,
borrowings including interest accrued on borrowings less cash and short-term deposits.

44. The Company does not have any has long term contracts or derivative contracts on which material foreseeable losses were
noted.

45. Other statutory information

(i) Based on the available information, the Company does not have any transactions with companies struck off under
section 248 of the Companies Act, 2013

(ii) The Company does not have any Benami property, where any proceeding has been initiated or pending against the
Company for holding any Benami property.

(iii) The Company has not traded or invested in Crypto currency or Virtual Currency during the financial year.

(iv) The Company does not have any such transaction which is not recorded in the books of accounts that has been
surrendered or disclosed as income during the year in the tax assessments under the Income Tax Act, 1961 such as,
search or survey or any other relevant provisions of the Income Tax Act, 1961.

(v) The Company has not advanced or loaned or invested funds to any other person(s) or entity(ies), including foreign
entities (Intermediaries) with the understanding that the Intermediary shall.

(a) directly or indirectly lend or invest in other persons or entities identified in any manner whatsoever by or on
behalf of the company (Ultimate Beneficiaries) or

(b) provide any guarantee, security or the like to or on behalf of the Ultimate Beneficiaries.

(vi) The Company has not received any fund from any person(s) or entity(ies), including foreign entities (Funding Party)
with the understanding (whether recorded in writing or otherwise) that the Comapany shall:

(a) directly or indirectly lend or invest in other persons or entities identified in any manner whatsoever by or on
behalf of the Funding Party (Ultimate Beneficiaries) or

(b) provide any guarantee, security or the like on behalf of the Ultimate Beneficiaries"

(vii) The Company is not declared as Wilful Defaulter by any Bank, financial Institution, governament or any regulatory
authority.

(viii) The Company does not have any charges or satisfaction which is yet to be registered with ROC beyond the statutory
period.

(ix) The company is not part of any group (as per the provisions of Core Investment Companies (Reserve Bank) Directions,
2016 as amended).

(x) The Company has not entered into any scheme of arrangement which has an accounting impact on current or previous
financial year.

(xi) The Company has complied with the number of layers of companies prescribed under clause (87) of Section 2 of the
Companies Act, 2013 read with Companies (Restriction on number of layers) Rules, 2017.

46. Initial Public Offer and utilization of proceeds

The Company successfully completed its Initial Public Offering (IPO) during the financial year ended March 31, 2022, issuing
17,573,342 equity shares with a face value of ?2 each. These shares were subsequently listed on the Bombay Stock Exchange
Limited (BSE) and the National Stock Exchange of India Limited (NSE). The IPO consisted of a Fresh Issue of 7,544,511 equity
shares, raising ?6,000.00 million, and an Offer for Sale of 10,028,831 equity shares by existing shareholders, amounting to
?7,982.95 million. Initially, the estimated Offer expenses were projected at ?536.83 million in the Prospectus. However, during
the year ended March 31,2025, the final actual expenses were determined to be ?521.16 million, slightly lower than the original
estimate. These expenses have been allocated proportionately between the Company and the selling shareholders, based on
their respective offer sizes. The Company's share of the final expenses, amounting to ?210.67 million, has been adjusted against
the Securities Premium account in accordance with the provisions of the Companies Act, 2013. The net proceeds received
from the IPO will be utilized for investment in a subsidiary to meet its working capital requirements and for general corporate
purposes.

Reason for change:

The ratio has increased from 0.03 in March 2025 to 0.05 in March 2026 mainly due to increase in net profit after tax, which is
mainly on account of increase in operations of the Company.

Note: Explanations for movement in ratios have been given only where the movement is more than 25%.